Ambry’s Classifi™ program represents a commitment to our clients to provide them with the highest quality test results, but Ambry’s no-stone-left-unturned commitment is not new. In fact, it is the reason so many people have trusted us for 25 years. Our Classifi program is simply putting a name to the layers of our expertise, our process and our use of cutting-edge technology to show our clients how we’ve always been different. Here, Dr. Kelly McGoldrick describes how an Ambry-initiated variant reclassification project provided updated results for over 7500 hereditary cancer testing patients. #Classifi #Ambry25 https://hubs.ly/Q02FRvbF0
Ambry Genetics’ Post
More Relevant Posts
-
Invion's Exec Chair and CEO, Thian Chew, explains the significance of the recent pre-clincal results undertaken by the Peter MacCallum Cancer Centre showing how dramatically INV043 can improve immune checkpoint inhibitor (ICI) therapies in this short 3min plus video. #cancerresearch #stockstowatch #biotech #cancertreatment #asx https://lnkd.in/gN4bw-Zg
IVX_PeterMacResults_20240311_FINAL
https://vimeo.com/
To view or add a comment, sign in
-
iBreastExam will revolutionize breast cancer detection forever! A painless, radiation-free test that delivers immediate results to women anywhere. A wireless device that requires minimal training and is currently being used worldwide to help women detect breast cancer as early as possible. This technology enables access to a precise and reliable screening, allowing women to know more about their breast health and take timely action to increase their chances of survival in case cancer is detected. Used by highly recognized professionals and supported by some of the most relevant institutions around the world, the hope of early detection is changing the face of breast cancer. Together we are defeating breast cancer around the world through early detection and innovation. Learn more at https://lnkd.in/dyJX-EZt #innovation #earlydetection #breastcancer #womenshealth #medtech #medicalinnovation #newtechnology
iBreastExam - Main Features
https://www.youtube.com/
To view or add a comment, sign in
-
📢 Exciting news from our network partner Qlucore! Their RNA-seq analysis tool, Qlucore Insights, is making big strides in pediatric acute lymphoblastic leukemia (ALL) treatment. This tech is not just about crunching data - it’s paving the way for more precise and personalized leukemia care. By identifying genetic changes, this software helps guide better treatment choices, keeping up with both current guidelines and the latest in disease research. Here’s to making targeted therapy even more targeted! #PrecisionMedicine #GeneticAnalysis #RNASeq https://lnkd.in/dJF3MQV3
To view or add a comment, sign in
-
CMO Oncology Consulting | Clinical Development | Strategy |Medical Affairs | IND | NDA | CDP | Protocol design | Phase 1 | FIH | Phase 3 | Go/NoGo | GNG | | acquisitions | data review | teaching | mentoring
mTPI study design for oncology phase 1 studies: a practical approach for the Medical Director and Clinical Scientist. Enjoy 28 minutes of teaching, and tell us what you want to see next. https://lnkd.in/gBmMxcpD
mTPI a practical approach
https://www.youtube.com/
To view or add a comment, sign in
-
A powerfull video from RUN DIPG captures the unimaginable pain that only #parents can truly even try to comprehend. On May 17th, #DIPG Pediatric Brain Cancer Awareness Day, we call upon your ingenuity and support. Together, we can find a cure, alleviate immense suffering, and prevent countless lost years and happy moments. https://lnkd.in/exw7y7Gs
RUN DIPG – Elastic Group
http://rundipg.org
To view or add a comment, sign in
-
Cancer is complex- with multiple mutations driving tumorigenesis, including in genes not previously associated with cancer. Each patient has on avg 5 genetic alterations with thousands of possible signatures per tumour type Vivan Therapeutics's variant calling software identifies these genetic alterations from the tumour sequence and give us a full picture of a patient’s cancer. We can think of as these as genomic constellations. Much like the constellations in our night sky. Each unique patient constellation benefits from a persoanalised therapeutic regimen. We have a deep dataset of patient tumour profiles matched with the most effective therapy based on massive in vivo (whole animal) drug screening. We utilise machine learning and AI on our data to inform patient treatment recommendations. Please contact Vivan Therapeutics at [email protected] to see how we can optimise your cancer treatment or inform your drug discovery/development. #cancer #cancertreatment #bowelcancer #coloncancer #colorectalcancer #pancreaticcancer #GIcancer #cancerbreakthrough #personalizedmedicine #bigdata #drugdevelopment #drugdiscovery
Vivan Therapeutics introduction
https://vimeo.com/
To view or add a comment, sign in
-
Smart and very innovative approach to fight cancer solid tumors.
Stromacare’s lead product candidate STRO-501 displays an innovative mechanism of action. Its ability to eliminate tumor through stroma modulation constitutes a real added value vs current therapies targeting only tumors. Learn more on this video. https://lnkd.in/ejJdNJZx
StromaCare: STRO-501
https://www.youtube.com/
To view or add a comment, sign in
-
On this #givingtuesday, I'd encourage you to take 3 minutes to listen to my story below. #SweatForBreath #lcam #lungcancerawareness #lungcancerawarenessmonth
David Cornbrooks: Living with ALK+ Lung Cancer
https://www.youtube.com/
To view or add a comment, sign in
-
Labcorp’s disseminated NALM6-Luc-mCh-Puro ALL model in NSG mice, established by our teams in house, provides yet another tool for the preclinical development of therapies directed against B-cell malignancies. We have characterized the response to CD19-targeted CAR T cell treatment and evaluated the activity and persistence using flow cytometry with expanded Persistence T panels. Find out more: https://lnkd.in/gPjHmbaa #AcuteLymphoblasticLeukemia #TumorModel #FlowCytometry
Modeling human acute lymphoblastic leukemia (ALL) – using the NALM6-Luc-mCh-Puro model for the development of CAR T cell therapies
learn-more.com
To view or add a comment, sign in
-
The objectives of the STREXIT 2 Project in the words of Dr Winan van Houdt, the Principal Investigator and Co-Leader of the STREXIT 2 Project STREXIT 2 is part of a series of clinical trials funded by the Horizon Europe programme. These trials, led by multistakeholder and multidisciplinary consortiums, form together the European Cancer Cluster. Watch this video, in which Dr Winan van Houdt, STREXIT 2’s Principal Investigator and Co-Leader from the The Netherlands Cancer Institute provides insights into the goals and potential impact of the project. https://lnkd.in/duHNmyFk Find out more about STREXIT 2: https://lnkd.in/eQuVVVyA #STREXIT2_Horizon #HorizonEurope #EUCancerMission #SARCOMA #CancerResearch #ClinicalTrials #Cancer #RetroperitonealSarcoma #SoftTissueSarcoma European Commission EORTC - European Organisation for Research and Treatment of Cancer Sarcoma Patient Advocacy Global Network (SPAGN) Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Syreon Research Institute
The STREXIT 2 Project
https://www.youtube.com/
To view or add a comment, sign in
Full-Time Missionary | Sharing the Love of Jesus Christ in Nigeria | The Church of Jesus Christ of Latter-day Saints | Port Harcourt Mission | Connect with me: [email protected]
1moHey, I stumbled upon your profile and was really impressed by your background and accomplishments. You clearly know your stuff. I'm always looking to connect with people who share my passions and interests. Would love to chat with you and learn from your experiences. Maybe we can even help each other out in some way. Looking forward to hearing from you.